Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;9(6):841-852.
doi: 10.1002/acn3.51564. Epub 2022 May 6.

Visual memory failure presages conversion to MELAS phenotype

Affiliations

Visual memory failure presages conversion to MELAS phenotype

Emily B Leaffer et al. Ann Clin Transl Neurol. 2022 Jun.

Abstract

Objective: To examine the correlation between verbal and visual memory function and correlation with brain metabolites (lactate and N-Acetylaspartate, NAA) in individuals with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS).

Methods: Memory performance and brain metabolites (ventricular lactate, occipital lactate, and occipital NAA) were examined in 18 MELAS, 58 m.3243A > G carriers, and 20 familial controls. Measures included the Selective Reminding Test (verbal memory), Benton Visuospatial Retention Test (visual memory), and MR Spectroscopy (NAA, Lactate). ANOVA, chi-squared/Fisher's exact tests, paired t-tests, Pearson correlations, and Spearman correlations were used.

Results: When compared to carriers and controls, MELAS patients had the: (1) most impaired memory functions (Visual: p = 0.0003; Verbal: p = 0.02), (2) greatest visual than verbal memory impairment, (3) highest brain lactate levels (p < 0.0001), and (4) lowest brain NAA levels (p = 0.0003). Occipital and ventricular lactate to NAA ratios correlated significantly with visual memory performance (p ≤ 0.001). Higher lactate levels (p ≤ 0.01) and lower NAA levels (p = 0.0009) correlated specifically with greater visual memory dysfunction in MELAS. There was little or no correlation with verbal memory.

Interpretation: Individuals with MELAS are at increased risk for impaired memory. Although verbal and visual memory are both affected, visual memory is preferentially affected and more clearly associated with brain metabolite levels. Preferential involvement of posterior brain regions is a distinctive clinical signature of MELAS. We now report a distinctive cognitive phenotype that targets visual memory more prominently and earlier than verbal memory. We speculate that this finding in carriers presages a conversion to the MELAS phenotype.

PubMed Disclaimer

Conflict of interest statement

Dr. Leaffer reports no financial and nonfinancial disclosure or conflict of interest. Dr. De Vivo reports no financial and nonfinancial disclosure or conflict of interest. Ms. Engelstad reports no financial and nonfinancial disclosure or conflict of interest. Dr. Fryer reports no financial and nonfinancial disclosure or conflict of interest. Dr. Gu reports no financial and nonfinancial disclosure or conflict of interest. Dr. Shungu reports no financial and nonfinancial disclosure or conflict of interest. Dr. Hirano reports no financial and nonfinancial disclosure of conflict of interests. Dr. DiMauro reports no financial and nonfinancial disclosure or conflict of interest. Dr. Hinton report no financial and nonfinancial disclosure or conflict of interest.

Figures

Figure 1
Figure 1
Brain metabolites by group.
Figure 2
Figure 2
Relationship between visual memory and brain metabolite ratios.
Figure 3
Figure 3
Relationship between verbal memory and brain metabolite ratios.

Similar articles

Cited by

References

    1. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16(4):481‐488. - PubMed
    1. Majamaa K, Moilanen JS, Uimonen S, et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet. 1998;63(2):447‐454. - PMC - PubMed
    1. Chinnery P, Johnson M, Wardell T, et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol. 2000;48(2):188‐193. - PubMed
    1. Darin N, Oldfors A, Moslemi AR, Holme E, Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol. 2001;49(3):377‐383. - PubMed
    1. Uusimaa J, Moilanen JS, Vainionpää L, et al. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A> G mutation in children. Ann Neurol. 2007;62(3):278‐287. - PubMed

Publication types